Home/Filings/5/A/0000906344-15-000005
5/A//SEC Filing

TriVascular Technologies, Inc. 5/A

Accession 0000906344-15-000005

CIK 0001432732operating

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:46 PM ET

Size

5.9 KB

Accession

0000906344-15-000005

Insider Transaction Report

Form 5/AAmended
Period: 2014-12-31
Kramer Michael R
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2013-11-29+32,04332,043 total
    Exercise: $8.93From: 2014-11-01Exp: 2023-11-29Common Stock (32,043 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the option are exercisable beginning on the one year anniversary of the vesting start date and in equal monthly installments thereafter over a four-year period.

Issuer

TriVascular Technologies, Inc.

CIK 0001432732

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001432732

Filing Metadata

Form type
5/A
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:46 PM ET
Size
5.9 KB